Victory Capital Management Inc. Purchases 16,641 Shares of Teleflex Incorporated (NYSE:TFX)

Victory Capital Management Inc. lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 47.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 52,011 shares of the medical technology company's stock after buying an additional 16,641 shares during the period. Victory Capital Management Inc. owned approximately 0.11% of Teleflex worth $9,257,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in TFX. Apollon Wealth Management LLC grew its stake in shares of Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company's stock worth $377,000 after purchasing an additional 55 shares in the last quarter. SRS Capital Advisors Inc. increased its stake in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company's stock valued at $4,844,000 after acquiring an additional 60 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its stake in Teleflex by 4.5% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company's stock valued at $375,000 after purchasing an additional 66 shares in the last quarter. HighTower Advisors LLC increased its position in shares of Teleflex by 1.7% during the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock valued at $986,000 after purchasing an additional 66 shares during the period. Finally, Huntington National Bank raised its stake in shares of Teleflex by 32.5% in the 3rd quarter. Huntington National Bank now owns 310 shares of the medical technology company's stock worth $77,000 after buying an additional 76 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Remove Ads

Teleflex Stock Up 1.4 %

NYSE:TFX traded up $1.89 during trading hours on Monday, hitting $139.60. 932,063 shares of the company's stock traded hands, compared to its average volume of 494,779. The stock's fifty day moving average price is $166.99 and its two-hundred day moving average price is $197.37. The firm has a market cap of $6.47 billion, a P/E ratio of 27.75, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex's dividend payout ratio (DPR) is currently 95.77%.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of research analyst reports. Royal Bank of Canada lowered Teleflex from an "outperform" rating to a "sector perform" rating and lowered their target price for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Piper Sandler reissued a "neutral" rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and decreased their price target for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Finally, Morgan Stanley decreased their target price on Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Teleflex presently has an average rating of "Hold" and an average price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.